PARP抑制联合胸部照射加重小鼠食管和皮肤毒性
该研究在荷Calu-6人肺癌异种移植瘤的裸鼠中评估BMN673联合分次照射(5 Gy×4)的抗肿瘤效果,并在C57BL6小鼠中评估BMN673或AZD2281联合全胸分次照射(5 Gy×4)的正常组织反应。结果显示PARP抑制增强照射对肿瘤生长的抑制,但也导致显著体重下降及照射野内食管和皮肤损伤加重,并损害这些组织中照射诱导的DNA损伤修复。
要点
- PARP抑制增强分次照射对裸鼠肿瘤生长的抑制。
- PARP抑制联合胸部照射加重小鼠体重下降及食管和皮肤损伤。
- PARP抑制损害食管和皮肤中照射诱导的DNA损伤修复。
核心结论
- PARP抑制在增强分次照射抗肿瘤反应的同时,也增强复制性正常组织对照射的反应,提示PARP抑制剂联合放疗的临床开发需额外谨慎。
研究设计与样本
- 在荷Calu-6人肺癌异种移植瘤的裸鼠中评估BMN673联合分次照射(5 Gy×4)的抗肿瘤效果。
- 在C57BL6小鼠中评估BMN673或AZD2281联合全胸分次照射(5 Gy×4)的正常组织反应。
- 检测指标包括体重、照射野内食管和皮肤组织学以及γH2AX免疫组化评估的DNA损伤反应。
主要发现
- PARP抑制增强照射诱导的裸鼠肿瘤生长抑制。
- PARP抑制联合胸部照射的C57BL6小鼠出现显著体重下降及照射野内食管和皮肤损伤增加。
- PARP抑制损害食管和皮肤中照射诱导的DNA损伤修复。
临床怎么用
- 临床联合PARP抑制剂与放疗时,尤其照射野包含食管时,需额外关注正常组织毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Poly (ADP-ribose) polymerase (PARP) inhibitors have been shown to enhance the radiosensitivity of cancer cells in vitro in a replication-dependent manner. Their in vivo radiosensitizing effects have also been demonstrated in preclinical tumor models. However, whether PARP inhibition can enhance the response to radiation therapy in normal tissues has been largely neglected. We hypothesized that PARP inhibition might also potentiate the response of replicating normal tissues to radiation therapy. In this study, we examined the normal tissue response in mice treated with PARP inhibitors (BMN673 or AZD2281) in combination with thoracic irradiation. METHODS AND MATERIALS: The antitumor effects of fractionated irradiation (5 Gy × 4) in combination with BMN673 were evaluated in nude mice bearing established Calu-6 human lung cancer xenografts. The normal tissue response was evaluated in C57BL6 mice that were treated with BMN673 or AZD2281 combined with fractionated irradiation, 5 Gy × 4, delivered to the whole thorax. Body weight and histology of the esophagus and skin in the field of irradiation were examined. The DNA damage response in the esophagus and skin was assessed by γH2AX immunohistochemistry. RESULTS: While PARP inhibition enhanced irradiation-induced tumor growth inhibition in nude mice, it was also associated with significant body weight loss and increased damage to the esophagus and skin within the field of irradiation in C57BL6 mice. PARP inhibition compromised the repair of irradiation-induced DNA damage in the esophagus and skin. CONCLUSIONS: Although PARP inhibition enhanced the antitumor response to fractionated irradiation, it also enhanced the irradiation response in replicating normal tissues. Therefore, our study suggests that additional caution may be warranted in the clinical development of combination therapies using PARP inhibitors and radiation therapy, in particular where the field of irradiation includes the esophagus.
引用
- Lourenco LM, Jiang Y, Drobnitzky N, et al. PARP Inhibition Combined With Thoracic Irradiation Exacerbates Esophageal and Skin Toxicity in C57BL6 Mice. Int J Radiat Oncol Biol Phys. 2017. PMID: 29413287. doi:10.1016/j.ijrobp.2017.10.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。